- Home
- RVPH vs WYY Comparison
RVPH vs WYY Comparison
Compare RVPH & WYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- WYY
- Stock Information
- Founded
- RVPH 2006
- WYY 1991
- Country
- RVPH United States
- WYY United States
- Employees
- RVPH N/A
- WYY N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- WYY EDP Services
- Sector
- RVPH Health Care
- WYY Technology
- Exchange
- RVPH Nasdaq
- WYY Nasdaq
- Market Cap
- RVPH 32.8M
- WYY 33.6M
- IPO Year
- RVPH N/A
- WYY 1998
- Fundamental
- Price
- RVPH $0.40
- WYY $3.24
- Analyst Decision
- RVPH Strong Buy
- WYY Strong Buy
- Analyst Count
- RVPH 5
- WYY 1
- Target Price
- RVPH $9.00
- WYY $7.00
- AVG Volume (30 Days)
- RVPH 3.8M
- WYY 66.9K
- Earning Date
- RVPH 08-13-2025
- WYY 08-13-2025
- Dividend Yield
- RVPH N/A
- WYY N/A
- EPS Growth
- RVPH N/A
- WYY N/A
- EPS
- RVPH N/A
- WYY N/A
- Revenue
- RVPH N/A
- WYY $142,582,209.00
- Revenue This Year
- RVPH N/A
- WYY $10.84
- Revenue Next Year
- RVPH N/A
- WYY $12.37
- P/E Ratio
- RVPH N/A
- WYY N/A
- Revenue Growth
- RVPH N/A
- WYY 24.03
- 52 Week Low
- RVPH $0.30
- WYY $2.19
- 52 Week High
- RVPH $4.28
- WYY $6.25
- Technical
- Relative Strength Index (RSI)
- RVPH 36.63
- WYY 47.68
- Support Level
- RVPH $0.38
- WYY $3.05
- Resistance Level
- RVPH $0.45
- WYY $3.46
- Average True Range (ATR)
- RVPH 0.04
- WYY 0.16
- MACD
- RVPH 0.01
- WYY 0.01
- Stochastic Oscillator
- RVPH 58.54
- WYY 42.22
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.